Taiho Oncology Displays Promising Oral Cancer Treatments at ASH 2025 At the ASH Annual Meeting 2025, Taiho Oncology presented groundbreaking Phase 2 results for oral cancer regimens, enhancing patient care.

Taiho Oncology Displays Promising Oral Cancer Treatments at ASH 2025 #United_States #Orlando #Taiho_Oncology #azacitidine #Cedazuridine